Study | Randomized | Treatment allocation concealed | Groups similar at baseline | Eligibility criteria specified | Outcome assessor blinded | Care provider blinded | Patient blinded | Variability measures | Intention-to-treat analysis | Total (max 9) |
---|---|---|---|---|---|---|---|---|---|---|
Abizanda [16] | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 7 |
Asplund [17] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |
Blanc-Bisson [18] | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 5 |
Counsell [19] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 6 |
1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 7 | |
De Morton [22] | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 5 |
Jones [23] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 5 |
Landefeld [24] | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 |
Laver [14] | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 7 |
Nikolaus [25] | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 6 |
1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 5 | |
Siebens [28] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 5 |
Slaets [29] | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 4 |